Lack of Support for the Genes by Early Environment Interaction Hypothesis in the Pathogenesis of Schizophrenia.


Journal

Schizophrenia bulletin
ISSN: 1745-1701
Titre abrégé: Schizophr Bull
Pays: United States
ID NLM: 0236760

Informations de publication

Date de publication:
21 01 2022
Historique:
pubmed: 15 5 2021
medline: 3 3 2022
entrez: 14 5 2021
Statut: ppublish

Résumé

Ursini et al reported recently that the liability of schizophrenia explained by a polygenic risk score (PRS) derived from the variants most associated with schizophrenia was increased 5-fold in individuals who experienced complications during pregnancy or birth. Follow-up gene expression analysis showed that the genes mapping to the most associated genetic variants are highly expressed in placental tissues. If confirmed, these findings will have major implications in our understanding of the joint effect of genes and environment in the pathogenesis of schizophrenia. We examined the interplay between PRS and obstetric complications (OCs) in 5 independent samples (effective N = 2110). OCs were assessed with the full or modified Lewis-Murray scale, or with birth weight < 2.5 kg as a proxy. In a large cohort we tested whether the pathways from placenta-relevant variants in the original report were associated with case-control status. Unlike in the original study, we did not find significant effect of PRS on the presence of OCs in cases, nor a substantial difference in the association of PRS with case-control status in samples stratified by the presence of OCs. Furthermore, none of the PRS by OCs interactions were significant, nor were any of the biological pathways, examined in the Swedish cohort. Our study could not support the hypothesis of a mediating effect of placenta biology in the pathway from genes to schizophrenia. Methodology differences, in particular the different scales measuring OCs, as well as power constraints for interaction analyses in both studies, may explain this discrepancy.

Identifiants

pubmed: 33987677
pii: 6275521
doi: 10.1093/schbul/sbab052
pmc: PMC8781344
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

20-26

Subventions

Organisme : Medical Research Council
ID : G0901310
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L010305/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0800509
Pays : United Kingdom
Organisme : Department of Health
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Références

Lancet Psychiatry. 2020 May;7(5):399-410
pubmed: 32220288
PLoS Genet. 2016 Feb 11;12(2):e1005765
pubmed: 26866486
Gigascience. 2019 Jul 1;8(7):
pubmed: 31307061
Cell. 2019 Dec 12;179(7):1469-1482.e11
pubmed: 31835028
Nature. 2014 Jul 24;511(7510):421-7
pubmed: 25056061
Br J Psychiatry. 2018 Sep;213(3):535-541
pubmed: 30113282
Schizophr Bull. 1999;25(3):413-23
pubmed: 10478777
Nature. 2018 Oct;562(7726):203-209
pubmed: 30305743
J Psychiatry Neurosci. 2018 Jul;43(4):245-253
pubmed: 29947606
J Psychiatr Res. 1994 Nov-Dec;28(6):519-30
pubmed: 7699611
Nat Med. 2018 Jun;24(6):792-801
pubmed: 29808008
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120
PLoS Comput Biol. 2015 Apr 17;11(4):e1004219
pubmed: 25885710
Mol Psychiatry. 2020 Jul;25(7):1430-1446
pubmed: 31969693
Am J Psychiatry. 2019 Sep 1;176(9):730-743
pubmed: 31055969
Am J Psychiatry. 2002 Jul;159(7):1080-92
pubmed: 12091183
Arch Gen Psychiatry. 1987 Jul;44(7):660-9
pubmed: 3606332
Nat Genet. 2013 Oct;45(10):1150-9
pubmed: 23974872
Epidemiol Psychiatr Sci. 2012 Sep;21(3):281-303
pubmed: 22794251
Psychiatry Res. 2011 May 30;187(3):335-40
pubmed: 21324530
Gigascience. 2015 Feb 25;4:7
pubmed: 25722852
Acta Psychiatr Scand. 1994 Mar;89(3):196-204
pubmed: 8178679
Eur Psychiatry. 2005 Jan;20(1):28-34
pubmed: 15642440
Genome Med. 2020 May 18;12(1):44
pubmed: 32423490
Eur J Epidemiol. 2019 Dec;34(12):1111-1117
pubmed: 32020465
Nat Genet. 2018 Mar;50(3):381-389
pubmed: 29483656
Biol Psychiatry. 2014 Jan 1;75(1):18-24
pubmed: 24135711
Psychol Med. 2020 Oct;50(13):2213-2220
pubmed: 31535606
Behav Genet. 2019 Mar;49(2):196-210
pubmed: 30467668
Am J Hum Genet. 2014 Sep 4;95(3):301-7
pubmed: 25152454
Nat Genet. 2019 Dec;51(12):1670-1678
pubmed: 31740837
Br Med J (Clin Res Ed). 1987 Sep 19;295(6600):681-2
pubmed: 3117295
Cell. 2018 Jun 14;173(7):1705-1715.e16
pubmed: 29906448

Auteurs

Evangelos Vassos (E)

Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
NIHR Maudsley Biomedical Research Centre, South London and Maudsley NHS Trust, London, UK.

Jiaqi Kou (J)

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

Sarah Tosato (S)

Section of Psychiatry, Department of Neuroscience, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.

Jessye Maxwell (J)

Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
NIHR Maudsley Biomedical Research Centre, South London and Maudsley NHS Trust, London, UK.

Charlotte A Dennison (CA)

Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, School of Medicine, Cardiff University, Cardiff, UK.

Sophie E Legge (SE)

Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, School of Medicine, Cardiff University, Cardiff, UK.

James T R Walters (JTR)

Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, School of Medicine, Cardiff University, Cardiff, UK.

Michael J Owen (MJ)

Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, School of Medicine, Cardiff University, Cardiff, UK.

Michael C O'Donovan (MC)

Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, School of Medicine, Cardiff University, Cardiff, UK.

Gerome Breen (G)

Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
NIHR Maudsley Biomedical Research Centre, South London and Maudsley NHS Trust, London, UK.

Cathryn M Lewis (CM)

Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
NIHR Maudsley Biomedical Research Centre, South London and Maudsley NHS Trust, London, UK.

Patrick F Sullivan (PF)

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Center for Psychiatric Genomics, Department of Genetics and Psychiatry, University of North Carolina, Chapel Hill, NC.

Christina Hultman (C)

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

Mirella Ruggeri (M)

Section of Psychiatry, Department of Neuroscience, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.

Muriel Walshe (M)

Division of Psychiatry, University College London, London, UK.

Elvira Bramon (E)

Division of Psychiatry, University College London, London, UK.

Sarah E Bergen (SE)

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

Robin M Murray (RM)

Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH